Shares of Allurion Technologies, Inc. (ALUR) tumbled nearly 11% on Wednesday morning after the company’s fourth-quarter (Q4) ...

Research analysts at Roth Capital cut their Q1 2025 earnings per share (EPS) estimates for Allurion Technologies in a report released on Wednesday, March 26th. Roth Capital analyst J. Wittes now ...

Reports Q4 revenue $5.6M, compared to $8.2M for the same period in 2023. The year-over-year decrease in revenue was primarily due to the ...

Allurion Technologies (NYSE:ALUR – Get Free Report) is anticipated to release its earnings data before the market opens on ...

Microcap Allurion Technologies (NYSE:ALUR) surged ~31% in after-hours trading Thursday after posting preliminary data on ...

Hello, everyone, and welcome to Allurion fourth quarter earnings call. Please note that this call is being recorded. After the speaker's prepared remarks, there will be a question and answer session.

Despite a dip in revenue, Allurion Technologies Inc (ALUR) showcases strategic advancements and a robust plan for future growth.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Allurion Technologies (ALUR – Research Report), ...

Shares of Allurion Technologies on Friday surged a day after the company said it received positive results about the effectiveness of its gastric balloon in combination with a low dose of the ...

Hello, everyone, and welcome to Allurion fourth quarter earnings call. Please note that this call is being recorded. After the speaker's prepared remarks, there will be a question and answer session.